The National Medical Products Administration approved Dupixent as an add-on maintenance treatment for adults with ...

The team found that for every standard deviation decrease in the thickness of the photoreceptor layer of the retina, the risk of non-hypertensive congestive heart failure increases by 25%, chronic ...

Data support Ohtuvayre™ (ensifentrine), as a first-in-class, selective, dual inhibitor of PDE3 and PDE4 in a broad COPD ...

China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...

The mission of Blessed Home Health Care in Oregon is to provide health services to patients in the comfort and dignity of their own home.

Which habit is common to some men, women and sadly, minors, but damages the heart and lungs, among other organs of the body?

The association is raising awareness to get babies the RSV antibody shot that is aimed at protecting them from severe systems ...

Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

After a delay, the FDA has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately ...

Regeneron and Sanofi on Friday said the green light covers Dupixent as an add-on maintenance treatment in certain adults with uncontrolled chronic obstructive pulmonary disease, or COPD, and makes ...

Regeneron (REGN) and Sanofi's (SNY) asthma therapy Dupixent receives FDA approval for label expansion in treating certain ...